Very good decision by retail investors. we should give the same reply to greedy promoters who either price their issues at very high prices or are from fundamentally weak compnies.
Do not put your money in this. Not much past history of the company, don't get lured by the chap price. No stock firm or daily has recommended it. In this market, better not to play risk, even if you think u can put 7,000 just to take chance, don't do that. Rest as always upto any one view.
Ammana Bio Pharma Ltd. Valuation - Anand Rathi Research
Company is operating in a sector, which is likely to receive favorable business climate for many years to come. However, company needs to prove its project execution skills & establish farmer sourcing network. At the Price band of Rs 12-14, issue is priced at 57x-67x its expected FY07 earnings, which is far more than the prevailing companies of similar size. Also, the significant dilution in promoter holdings post-issue is a cause of concern. Keeping these execution risks & high price in mind, we recommend our investors to AVOID the issue.
avoid these Ipo,not reputed group,taking advantage of Bio pharma group is changed company name and company is nothing to do in future,just enjoying themselves with our money.in short keep your self 100 killometer far from these Ipo
Market Lot: 500 Shares »» Minimum Order Quantity: 500 Shares .... Why this type of lot? What is hidden behind this calculation? Can anyone explain this statistics?
Following are excerpts from RH Prospectous ------------------------------------------ Current Book value(for face value Rs.10 share) is Rs.9.41.
Current Earnings per share is 0.122 (nearly 12 paise per Rs.10).
Commercial production started in March 2006.
Futuristic industry but with stiff competion.
Company has paid only 25% advance for purchase of machinery worth 2.50 crores. But not even placed orders for SweetSorghum project. This indicates that there may be delay in future projects and consequent delay in riping the benefits.
Skill manpower is not yet recruited. This will also delay the project.
The price of main raw material is suspectible to volatality. Any increase might decrease future profits and any decrease might increase the future profits.
The promoter company Ammana Equity Fund Private Limited did not have any operations for several years.
The company had negative cash flow till December 2006.
My Opinion ----------
Good for Long Term (3 to 5 years) and listing gains. The share, becasue it is offered at Rs.12 to Rs.14, depending upon the then market conditions, will get listed between Rs.18 and Rs.20. Then settle down around the issue price for quite some years and thereafter gradually increase based on the performance.
This got very good potential for growth. Bio fuel is alreadt fully operational in some states of India. Givt is now promoting bio fuel based companies and get lot of benefits